InPharm - Research and Development
Bristol-Myers Squibb and AstraZeneca prepare phase IV trial for their diabetes treatment
Gains MS and cancer candidates through Facet Biotech deal
Staff take to the streets over decision to shut Verona R&D facility
Search and referral engine TrialReach launches with patient-friendly promise
Appointments
Bristol-Myers Squibb has appointed Lamberto Andreotti its new chief executive with effect from 4 May, succeeding James Cornelius who will remain...
